Neuro-oncology.dukejournals.org

Neuro Oncology Dukejournals. Ranked above all other neuro-oncology journals in the Journal Citation Reports®

What’s new on Neuro-oncology.dukejournals.org: Check updates and related news right now. This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Neuro-oncology.dukejournals.org popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Neuro Oncology Dukejournals

Subscribe to related news

SNO Journals
via soc-neuro-onc

One of the many benefits of a Society for Neuro-Oncology Membership is a subscription to Neuro-Oncology and Neuro-Oncology Practice. Neuro-Oncology is the official journal of the Society for Neuro-Oncology, the Japan Society for Neuro-Oncology, the...
Gökalp Silav
via acibademinternational

Gökalp Silav Associate Professor; Neurosurgery Birth Date: 01. May. 1970 Birth place: Suleoglu / Edirne Education: 1987-1994 M.D. degree in Ankara university, Faculty of Medicine, Ankara, Turkey 1995-2001 Neurosurgery residency, Department...
Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association fo...
via serval.unil

Hoang-Xuan K., Bessell E., Bromberg J., Hottinger A.F., Preusser M., Rudà R., Schlegel U., Siegal T., Soussain C., Abacioglu U., Cassoux N., Deckert M., Dirven C.M., Ferreri A.J., Graus F., Henriksson R., Herrlinger U., Taphoorn M., Soffietti R., Weller...
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the ...
via academic.oup

This guideline provides recommendations for the use of PET imaging in gliomas. The review examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) and amino acid tracers (11C-MET, 18F-FET, and 18F-FDOPA). An increasing...
Angiochem's ANG1005 Shows Clinical Benefits and Prolonged Survival for Breast Cancer Patients With Brain Metastases
via saudieyeonbusiness

MONTREAL, QC—(Marketwired – October 17, 2016) – Angiochem, a biotechnology company developing peptide–drug conjugates uniquely capable of crossing the blood–brain barrier, recently presented data from its Phase II trial for its lead compound, ANG100...

Neuro-oncology.dukejournals.org popular pages

Index of /

Neuro-Oncology is the leading journal in the field, ranked above all other neuro-oncology journals in the Journal Citation Reports®. Dedicated to providing superior and rapid publication of informat...